Hepatocellular carcinoma in explanted livers of patients with genotype D HBV cirrhosis: Report of the first experience from Iran

Archives of Iranian Medicine

Volumn 16, Issue 6, 2013, Pages 348-350

  Geramizadeh, Bita ^a,b   Nikeghbalian, Saman ^a,b   Kazemi, Kurosh ^a   Shamsaifar, Alireza ^a   Bahador, Ali ^a   Salahi, Heshmatollah ^a   Malekhosseini, Seyed Ali ^a   Kashtkar Jahromi, Marzieh ^a   Bakhshai Dehkordi, Ali ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Explanted liver; Genotype D; Hepatocellular carcinoma

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CHILD; DISEASE ASSOCIATION; EXPLANT; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IRAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ALPHA-FETOPROTEINS; ASPARTATE AMINOTRANSFERASES; CARCINOMA, HEPATOCELLULAR; CHILD; DNA, VIRAL; END STAGE LIVER DISEASE; FEMALE; FIBROSIS; HEPATECTOMY; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IRAN; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84878856438     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007; 132: 2557-2576.
2. Yuen MF, Hou JL, Chutaputti A. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol. 2009; 24: 346-353.
3. Mojiri A, Behzad-Behbahani A, Saberfirozi M, Ardabili M, Behshti M, Rahsaz M, et al. Hepatitis B virus genotypes in South West Iran: molecular, serological, and clinical outcomes. World J Gastroenterol. 2008; 14: 1510-1513.
4. Poustchi H, Sepanlou SG, Esmaili S, Mehrabi N, Ansarymoghadam A. Hepatocellular carcinoma in the world and the middle East. MEJD. 2010; 2: 1-19.
5. Lin CL, Kao JH. The clinical implications of hepatitis B virus genotypes: recent advances. J GasttOentemlHepatol. 2011; 26 (suppl 1): 123-130.
6. Jazag A, Puntsagdulam N, Chinburen J. Status quo of chronic liver diseases, including hepatocellular carcinoma, in Mongolia. Korean J Intern Med. 2012; 27: 121-127.
7. Mohammadnejad L, Farajnia S, Parivar K, Naghili B, Yousef Zadeh Kheirnagsh R. Hepatitis B virus genotypes in Eastern Azerbaijan, north-west Iran. Arch Iran Med. 2012; 15: 446-448.
8. Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol. 2011; 26 (suppl 1): 123-130.
9. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012; 142: 1264-1273.
10. Geramizadeh B, Kaboli R, Behzad-Behbahani A, Rahsaz M, Azarpira N, Aghdai M, et al. A nested PCR method for the identification of hepatitis B virus genotype in paraffin blocks of formalin-fixed liver biopsies. Arch Iran Med. 2008; 11: 455-458
11. Barazani Y, Hiatt JR, Tong MJ, Busuttil RW. Chronic viral hepatitis and hepatocellular carcinoma. World JSurg. 2007; 31: 1243-1248.
12. Poustchi H, Mohamadkhani A, Bowden S, Montazeri G, Ayres A, Revill P, et al. Clinical significance of precore and core promoter mutations in genotype D hepatitis B related chronic liver disease. J Viral Hepatitis. 2008; 15: 753-780.
13. Nguyen T, Law MG, Dore GJ. Hepatitis B related hepatocellular carcinoma: epidemiological characteristics and disease burden. J Viral Hepatol. 2009; 16: 453-463.
14. Chan HY-L, Tse CH, Mo F, Koh J, Wong VWS, Wong GLH, et al. High viral load and hepatitis B virus subgenotype Ce are associated with increased risk of hepatocellular carcinoma. J Clin Oncol. 2008; 26: 177-182.
15. Yuen MF, Tanaka Y, Mizokami M, Yuen JCH, Wong DKH, Yuan HJ, et al. Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study. Carcinogenesis. 2004; 25: 1593-1598.
16. Lin CL, Kao JH. The clinical implication of hepatitis B virus genotype. Recent advances. J Gastroenterol Hepatol. 2011; 26 (suppl 1): 1230.
17. Kao JH. Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan. Intervirology. 2003; 46: 400-407.
18. Han YF, Zhao J, Ma LY, Yin JH, Chang WJ, Zhang HW, et al. Factors predicting occurrence and prognosis of hepatitis B-virus-related hepatocellular carcinoma. WorldJ Gastroenterol. 2011; 17: 38.
19. Eftekhari Y, Kazemi Arababadi M, Hakimi H, Rezazadeh Zarandi E. Common HBV genotype in Southeastern Iranian patients. Arch Iran Med. 2010; 13: 147-149.
20. Aghakhani A, Hamkar R, Zamani N, Eslamifar A, Banifazl M, Sasdat A, et al. Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma. Int J Infect. 2009; 13: 685-689.
21. Livingston SE, Simonetti JP, McMohan BJ, Bulkow LR, Hurlburt J, Homan CE, et al. Hepatitis B virus genotypes in Alaska native people with hepatocellular carcinoma: preponderance of genotype F. JID. 2007; 195: 5-11.
22. Venook AP, Papandreou C, Furuse J, Ladron De Guevara L. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. The Oncologist. 2010; 15: 5-13.
23. Yang H, Yeh SH, Chen P, Iloeje UH, Jen CL, Su J, et al. Association between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst. 2008; 100: 1134-1143.
24. Sharma S, Sharma B, Singla B, Chawla YK, Chakraborti A, Sainin N, et al. Clinical significance of genotypes and precore/basal core promoter mutations in HBV related chronic liver disease patients in North India. DigDisSci. 2010; 55: 794-802